Aspire Biopharma Holdings, Inc. - ASBP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Highbridge Capital Management, LLC | 0.0% | 78 | View |
| Aug 10, 2026 | SCHEDULE 13G | GARY SHIRINYAN | 7.7% | 99,900 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | Lance Friedman | 7.92% | 107,323 | View |
| Jul 02, 2026 | SCHEDULE 13G | Rubenbauer Alois Ryan III | 5.0% | 65,000 | View |
| May 15, 2026 | SCHEDULE 13G | Highbridge Capital Management, LLC | 5.2% | 273,000 | View |
| May 13, 2026 | SCHEDULE 13G/A | Ardsley Advisory Partners LP | 0.0% | 0 | View |
| May 13, 2026 | SCHEDULE 13G/A | Ardsley Advisory Partners GP LLC | 0.0% | 0 | View |
| May 13, 2026 | SCHEDULE 13G/A | Ardsley Partners I GP LLC | 0.0% | 0 | View |
| May 13, 2026 | SCHEDULE 13G/A | Ardsley Partners Advanced Healthcare Fund, L.P. | 0.0% | 0 | View |
| May 13, 2026 | SCHEDULE 13G/A | Ardsley Partners Fund II, L.P. | 0.0% | 0 | View |
| May 13, 2026 | SCHEDULE 13G/A | Philip J. Hempleman | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.